BGLC
BioNexus Gene Lab Corp
+0.04 (+2.78%)1.48USD4.8K成交股數4.3M市值–本益比(近四季)1.4股價營收比-96.6%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 76K-97% | 23K-99% | 484K-82% | 2.5M+29% | 2.3M-5% | 2.1M-6% | 2.6M+3% | 2.0M-23% | 2.4M | 2.3M | 2.6M | 2.6M |
| 營業成本 | 63K | 24K | 488K | 2.2M | 1.9M | 1.8M | 2.3M | 1.7M | 2.0M | 2.0M | 2.2M | 2.2M |
| 毛利 | 13K-96% | −790.00-100% | −4K-101% | 378K+31% | 368K+1% | 343K+29% | 327K-8% | 289K-15% | 365K | 267K | 354K | 340K |
| 毛利率 | 17.0% | -3.5% | -0.8% | 14.8% | 16.3% | 16.1% | 12.4% | 14.6% | 15.3% | 11.7% | 13.9% | 13.2% |
| 研發費用 | 14K | 14K | 11K | 15K | 13K | 12K | 10K | 8K | 11K | – | – | – |
| 銷售管理費用 | 299K | 328K | 181K | 446K | 517K | 392K | 792K | 559K | 316K | −2.0M | 3.1M | 807K |
| 營業利益 | −282K-54% | −540K-13% | −1.0M-23% | −703K-371% | −611K+674% | −618K-340% | −1.3M-47% | 259K-195% | −79K | 258K | −2.5M | −272K |
| 營業利益率 | -370.8% | -2,366.2% | -213.5% | -27.6% | -27.0% | -28.9% | -50.9% | 13.1% | -3.3% | 11.3% | -99.0% | -10.6% |
| 稅後淨利 | −286K-54% | −544K-13% | −1.0M-23% | −709K-456% | −616K+494% | −623K-302% | −1.3M-48% | 199K-177% | −104K | 308K | −2.6M | −259K |
| 淨利率 | -376.1% | -2,379.7% | -214.2% | -27.9% | -27.3% | -29.2% | -51.1% | 10.1% | -4.4% | 13.6% | -102.2% | -10.1% |
| 稀釋 EPS | -0.12-66% | -0.23-35% | – | -0.40-450% | -0.34+5617% | -0.35 | -0.75 | 0.11 | -0.01 | – | – | – |
| 稀釋股數 | 2.4M | 2.4M | – | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 17.7M | 15.9M | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.2M | 1.3M | 2.4M | 1.2M | 1.5M | 2.1M | 4.1M | 5.4M | 4.4M | 4.5M | 6.1M | 1.8M |
| 應收帳款 | 16K | 80K | 506K | 1.5M | 1.9M | – | – | – | – | – | – | – |
| 存貨 | 653K | 667K | 677K | 1.0M | 1.2M | 1.2M | 1.4M | 1.0M | 1.1M | 1.1M | 1.1M | 1.2M |
| 總資產 | 8.7M | 9.0M | 9.3M | 7.6M | 9.4M | 9.5M | 11.0M | 11.1M | 11.2M | 11.4M | 11.5M | 7.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 948K | 947K | 638K | 805K | 1.9M | 1.7M | 1.6M | 1.6M | 1.8M | 1.7M | 1.8M | 1.9M |
| 股東權益 | 7.8M | 8.1M | 8.6M | 6.8M | 7.5M | 7.8M | 9.4M | 9.5M | 9.3M | 9.7M | 9.3M | 5.6M |
| 負債比 | 10.9% | 10.5% | 6.9% | 10.6% | 20.2% | 18.0% | 14.6% | 14.3% | 16.3% | 15.3% | 15.5% | 24.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −148K-82% | – | – | – | −824K | – | – | −37K | – | – | – |
| 資本支出 | – | 325.00 | – | – | – | 9K | – | – | 22K | – | – | – |
| 自由現金流 | – | −148K-82% | – | – | – | −833K | – | – | −59K | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -647.9% | – | – | – | -39.0% | – | – | -2.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 6.7M
| MY | 5.8M | 86.4% | -21.8% |
|---|---|---|---|
| LK | 453K | 6.7% | -1.4% |
| 新加坡 | 241K | 3.6% | -57.9% |
| ID | 115K | 1.7% | -16.9% |
| BD | 106K | 1.6% | -13.8% |
| MV 小計 | 681K | 10.1% | -10.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 7.4M | -21.9% | −3.0M | -40.2% | – | −1.9M |
| FY2024 | 9.5M | -2.7% | −1.6M | -16.8% | -0.09 | −2.3M |
| FY2023 | 9.8M | -10.6% | −2.6M | -26.9% | -0.17 | −2.0M |
| FY2022 | 10.9M | -18.2% | −356K | -3.3% | – | 552K |
| FY2021 | 13.4M | +17.3% | 752K | 5.6% | – | 6K |
| FY2020 | 11.4M | +8872.0% | 1.1M | 9.6% | 0.01 | 131K |
| FY2019 | 127K | -40.2% | −246K | -194.1% | 0.00 | −230K |
| FY2018 | 212K | – | 26K | 12.5% | 0.00 | −314K |